Stock

BridgeBio Oncology Therapeutics, Inc. BBOT

$8.84+1.49%

All stocks Create account to unlock

Overview

BBOT market data

Price History

BBOT price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for BBOT. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

6 captured

Penguin Solutions, Beazer Homes, Alibaba And Other Big Stocks Moving Higher On Wednesday · Jul 8, 2026, 2:20 PM

8-K filing — BridgeBio Oncology Therapeutics, Inc. (BBOT) · Jun 22, 2026, 8:05 PM

Oppenheimer Assumes BridgeBio Oncology at Outperform, Announces Price Target of $22 · Jun 22, 2026, 5:35 PM

BridgeBio Oncology Q1 EPS $(526.11) Down From (54.230) YoY, · May 12, 2026, 10:00 PM

This Arxis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday · May 11, 2026, 1:31 PM

Canaccord Genuity Initiates Coverage On BridgeBio Oncology with Buy Rating, Announces Price Target of $23 · May 11, 2026, 11:51 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock